Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

Psychedelic therapy for depression: A DMT approach

PS2023-238-tn
Clinical Trials

Psychedelic therapy for depression: A DMT approach

Work from psychedelic trials in depression will be presented, with focus on recent SmallPharma (with Imperial as key collaborator) DMT study in major depression.

Share: Psychedelic therapy for depression: A DMT approach

Facebook
Twitter
LinkedIn
Email

Related Videos

Screenshot 2024-06-27 at 11.53.02 AM
Texas Eclipse 2024
The Mycologist & The Doctor: Psilocybin in Nature & Medicine
Screenshot 2024-06-27 at 12.55.02 PM
Texas Eclipse 2024
Zendo Project: Providing Support During Non-Ordinary States of Consciousness
Screenshot 2024-06-27 at 11.48.39 AM
Texas Eclipse 2024
The Art of Simmering in MDMA-Assisted Therapy

© 1986 – 2023 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. 
3141 Stevens Creek Blvd #40563, San Jose, CA 95117
Disclaimer | Privacy Policy

Report an Error

Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!
Login Now
Login Now

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.

Register for PS2023
Register for PS2023